77758-50-0

Basic information

• Product Name: Pent-4-ynyl p-Tosylate
• Synonyms: 4-Pentyn-1-ol 4-Methylbenzenesulfonate;4-Pentyn-1-ol Tosylate;4-Pentynyl p-Tosylate;5-(p-Toluenesulfonyloxy)pent-1-yne;5-(Tosyloxy)-1-pentyne;Pent-4-ynyl p-Tosylate;1-Tosyloxy-4-pentyne
• CAS NO: 77758-50-0
• Molecular Formula: C₁₂H₁₄O₃S
• Molecular Weight: 238.3
• Product Categories: Aliphatics;Sulfur & Selenium Compounds
• Mol File: 77758-50-0.mol
• Article Data: 54

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: Pent-4-ynyl p-Tosylate(CAS DataBase Reference)
• NIST Chemistry Reference: Pent-4-ynyl p-Tosylate(77758-50-0)
• EPA Substance Registry System: Pent-4-ynyl p-Tosylate(77758-50-0)

Safety Data

• Hazardous Substances Data: 77758-50-0(Hazardous Substances Data)

Usage

Uses

4-Pentynyl p-Tosylate, 90% (cas# 77758-50-0) is a compound useful in organic synthesis.

Upstream product

• 5390-04-5 pent-1-yn-5-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 104-15-4 toluene-4-sulfonic acid 
• 6089-09-4 4-pentynoic acid 
• 98-68-0 4-methoxy-phenyl-sulphonyl chloride 

Downstream Products

• 93131-32-9 dimethyl(phenyl)silylmethylenecyclobutene 
• 679002-02-9 1-azido-4-(phenylsulfonyl)hepta-4,5-diene 
• 679002-04-1 6-azido-2-methyl-4-(phenylsulfonyl)hepta-2,3-diene 
• 679002-03-0 1-azido-4-(phenylsulfonyl)deca-4,5-diene 

Relevant articles and documents

Radiosynthesis and biological evaluation of an fluorine-18 labeled galactose derivative [18F]FPGal for imaging the hepatic asialoglycoprotein receptor

The asialoglycoprotein receptor (ASGPR) is abundantly expressed on the surface of hepatocytes where it recognizes and endocytoses glycoproteins with galactosyl and N-acetylgalactosamine groups. Given its hepatic distribution, the asialoglycoprotein recept

Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy

The alkenyldiarylmethanes (ADAMs) are a class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) targeting HIV-1. Four chemically and metabolically stabilized ADAMs incorporating N-methoxyimidoyl halide replacements of the methyl esters of the lead compound were previously reported. In this study, twenty-five new ADAMs were synthesized in order to investigate the biological consequences of installing nine different methyl ester bioisosteres at three different locations. Attempts to define a universal rank order of methyl ester bioisosteres and discover the 'best' one in terms of inhibitory activity versus HIV-1 reverse transcriptase (RT) led to the realization that the potencies are critically dependent on the surrounding structure at each location, and therefore the definition of universal rank order is impossible. This investigation produced several new non-nucleoside reverse transcriptase inhibitors in which all three of the three methyl esters of the lead compound were replaced by methyl ester bioisosteres, resulting in compounds that are more potent as HIV-1 RT inhibitors and antiviral agents than the lead compound itself and are expected to also be more metabolically stable than the lead compound.

Copper-Catalyzed Perfluoroalkylation of Alkynyl Bromides and Terminal Alkynes

A copper-catalyzed one-pot perfluoroalkylation of alkynyl bromides and terminal alkynes has been disclosed, and the corresponding perfluoroalkylated alkynes could be attained in good to excellent yields. The new straightforward transformation shows high efficiency (0.01-0.5 mol % catalyst loading), broad substrate scope, and remarkable functional group tolerance and provides a facile approach for useful application in life and material sciences.

SMARCA DEGRADERS AND USES THEREOF

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are bifunctional molecules that link a cereblon-binding moiety to a ligand that binds SMARCA and/or PB1 proteins.